User banner image
User avatar
  • admin

Posts

CervoMed Announces Oral Presentation at 19th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurologic Disorders (AP/PD™)

BOSTON, March 25, 2025 (GLOBE NEWSWIRE) — CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced...

Akebia Therapeutics Announces Poster Presentations at NKF Spring Clinical Meetings 2025

CAMBRIDGE, Mass., March 25, 2025 (GLOBE NEWSWIRE) — Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people...

Avadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with Narcolepsy and Their Clinicians

DUBLIN, March 25, 2025 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today announced the publication...

Prime Biome Reviews (Is It Legit And Safe Ingredients?) Can This Probiotic Really Transform Your Skin And Gut?

BOSTON, March 25, 2025 (GLOBE NEWSWIRE) — The Prime Biome probiotic supplement that has been garnering attention in the health supplement industry is a unique...

LIFE Advanced Integrated Dentistry Announces Launch of Prevention-Focused, Precision-Driven, Personalized Dental Care in Alexandria, VA

Alexandria, Virginia, March 25, 2025 (GLOBE NEWSWIRE) — LIFE Advanced Integrated Dentistry (lifedentistrynova.com) is excited to announce the launch of its prevention-focused, precision-driven, personalized dental...

AB DAO Global Recall Continues: 65 Million NEW-09E Still Awaiting Conversion to $AB

SINGAPORE, March 25, 2025 /PRNewswire/ — AB DAO announced today that its global recall initiative has achieved phased success: so far, 28 BEP2 NEW (NEW-09E) token...

Pony.ai FY2024 Revenue Hits Record High After 3-Yrs Growth

GUANGZHOU, China, March 25, 2025 /PRNewswire/ — On March 25th, Pony.ai (Nasdaq: PONY) announces unaudited Q4 and FY2024 financial results. FY total revenue rose to US$75.0...

AccurEdit Therapeutics’ LNP-based In Vivo Gene Editing Product ART001 Obtained Orphan Drug Designation from the FDA

CAMBRIDGE, Mass., March 25, 2025 /PRNewswire/ — AccurEdit Therapeutics today announced that its innovative in vivo gene editing product, ART001, has obtained Orphan Drug Designation...

OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer

BASEL, Switzerland, March 25, 2025 /PRNewswire/ — OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company dedicated to advancing healthcare outcomes and improving the quality of...

OMNICOM MEDIA GROUP TOPS 2024 TOTAL NEW BUSINESS RANKING WITH $7.7 BILLION

COMvergence Report Shows OMG #1 for Retention, Holding on to 74% of Its Billings in Play in a Year When the Industry Average Was Only...